about
Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescentsLi-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapyZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.Pediatric follicular lymphoma in Japan.Primary mediastinal large B-cell lymphoma in Japanese children and adolescents.Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation.Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case reportPoor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.Two cases of neuroblastoma comprising two distinct clones.Large congenital melanocytic nevi with atypical teratoid/rhabdoid tumor.Somatic MECOM mosaicism in a patient with congenital bone marrow failure without a radial abnormality.A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS.Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.Treatment of pediatric lymphoma in Japan: Current status and plans for the future.Successful treatment of systemic EBV positive T-cell lymphoma of childhood using the SMILE regimen.DIPG-31. CLINICO-PATHOLOGICAL REVIEW OF 26 CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA.Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNADiplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasmsA prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioningRecurrentRARBTranslocations in Acute Promyelocytic Leukemia LackingRARATranslocationB-lymphoblastic lymphoma with fusion geneLGG-41. BEVACIZUMAB FOR PEDIATRIC LOW GRADE GLIOMA.ATRT-32. PREPARATION OF GENETIC TESTING SYSTEM OF AT/RT FOR PEDIATRIC CANCER PREDISPOSITION PROGRAM.The germline TP53 mutation c.722 C>T promotes bone and liver tumorigenesis at a young ageSuccessful treatment of metastatic rhabdomyosarcoma with radiochemotherapy and allogeneic hematopoietic stem cell transplantation[LMB chemotherapy for mature B-cell neoplasms in children: a single-center experience]B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature ReviewA Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in ChildrenSuccessful Umbilical Cord Blood Transplantation With Reduced-intensity Conditioning for Acute Myeloid Leukemia in a Child With Shwachman-Diamond SyndromeHigh prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumorsPathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patientsA Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-armThe Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study
P50
Q30009508-F7E38192-1D5A-4800-8BE8-82D5E1744908Q33822062-FB25264C-B80F-4CD7-9DEE-25576A0F5105Q34432525-EA14A1B7-FEE5-49C6-917C-AD13CC4EF5C7Q37555816-63F55321-7F86-4381-9E0E-5849809CE69BQ38921889-D5362144-9665-4E1F-898C-19D373C25E65Q39011844-A055D41D-7C3C-4CBA-871D-1D3806FCF996Q39244011-1608242B-A580-4051-ACF9-2FDB0BC9273FQ40079621-5115C1F1-A260-452F-8ED1-1BEB9098E9A9Q40695241-30C7D4D2-F094-433E-838D-D36DFB69FAB6Q41698420-31B682A4-1683-45C7-A3BA-058F28700BB5Q41960423-7EB1F88B-DA57-4850-AA26-CF86A926BE83Q44712646-A5A19469-0B16-4206-AA84-D63D95B585ABQ46497123-651CDA40-D4F2-46F4-BA80-BEC34EBAB0CDQ48114928-F2BCF8FB-AFBB-41F6-9987-177B4CC3BF09Q48196321-7BE92D05-B5AA-4A2C-A893-CA4600F295E4Q50007048-E039C6E7-54CF-45B2-B8CC-AE181FE3084FQ50120726-8A7D9544-8FEC-44B9-8812-494E3B4D153CQ50446340-F89673CE-4417-4696-B4D9-7CDB9DA1B4FCQ51118982-BD338971-DA33-4183-958B-E8CFC7B095DAQ52888397-34FC673E-BCAF-4A1F-A476-313BB2FF042BQ52935778-7FF929FB-1C4B-4A6E-BA72-83787C64D175Q54237070-8802D747-4587-45F4-968B-FC70F7BFD184Q54917875-35DA0AA4-649A-4DEB-AC52-6BFF785E90AAQ57518084-6E37B1D6-8757-46B7-B4E8-0FA19462408CQ57518085-DC37F016-97BC-4725-BC65-64B0183BB4F5Q57518087-2547D231-F934-4D43-A7A6-422D3515D4BDQ57518090-5C251920-7132-4F99-A3A1-F1208FDF1962Q60922708-B8B403E3-9094-4CE0-BAF5-9624472244D8Q64917443-997AEBC7-72D8-424B-8385-B4400819C7A7Q64922704-F07943BA-F2BF-4E35-A91C-E18F0CC9AA7FQ84782946-83D74240-974C-41F6-B765-A5C2C96B54BBQ85965082-53B530A4-400E-4DD9-ADBC-7040B0715D3DQ89179421-F123AE3E-D401-49BA-A0EB-047122EADFF4Q89755882-5FA05DBA-2460-4CEF-B68B-04523E527ABFQ89883033-4725E169-0877-4B58-979D-31471B5532A6Q90064590-1AFE3B23-4F2E-41D0-95EA-C0F9E149ECF5Q90696113-C6CD614A-8048-4A13-BAB6-0D241541E533Q90833352-06F011AF-8F46-48CA-B07E-A325306C54ECQ91114852-8D5383CD-B8C5-49F6-80BB-4A4B060B5D34Q91114856-CC8CE969-060B-450F-9BC8-8E42313AE791
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Tomoo Osumi
@en
Tomoo Osumi
@nl
type
label
Tomoo Osumi
@en
Tomoo Osumi
@nl
prefLabel
Tomoo Osumi
@en
Tomoo Osumi
@nl
P31
P496
0000-0001-5536-6788